Cargando…
Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin
AIMS/HYPOTHESIS: The action of incretin hormones including glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) is potentiated in animal models defective in glucagon action. It has been reported that such animal models maintain normoglycaemia under streptozotocin (S...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901104/ https://www.ncbi.nlm.nih.gov/pubmed/27053237 http://dx.doi.org/10.1007/s00125-016-3935-2 |
_version_ | 1782436744824619008 |
---|---|
author | Iida, Atsushi Seino, Yusuke Fukami, Ayako Maekawa, Ryuya Yabe, Daisuke Shimizu, Shinobu Kinoshita, Keita Takagi, Yusuke Izumoto, Takako Ogata, Hidetada Ishikawa, Kota Ozaki, Nobuaki Tsunekawa, Shin Hamada, Yoji Oiso, Yutaka Arima, Hiroshi Hayashi, Yoshitaka |
author_facet | Iida, Atsushi Seino, Yusuke Fukami, Ayako Maekawa, Ryuya Yabe, Daisuke Shimizu, Shinobu Kinoshita, Keita Takagi, Yusuke Izumoto, Takako Ogata, Hidetada Ishikawa, Kota Ozaki, Nobuaki Tsunekawa, Shin Hamada, Yoji Oiso, Yutaka Arima, Hiroshi Hayashi, Yoshitaka |
author_sort | Iida, Atsushi |
collection | PubMed |
description | AIMS/HYPOTHESIS: The action of incretin hormones including glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) is potentiated in animal models defective in glucagon action. It has been reported that such animal models maintain normoglycaemia under streptozotocin (STZ)-induced beta cell damage. However, the role of GIP in regulation of glucose metabolism under a combination of glucagon deficiency and STZ-induced beta cell damage has not been fully explored. METHODS: In this study, we investigated glucose metabolism in mice deficient in proglucagon-derived peptides (PGDPs)—namely glucagon gene knockout (GcgKO) mice—administered with STZ. Single high-dose STZ (200 mg/kg, hSTZ) or moderate-dose STZ for five consecutive days (50 mg/kg × 5, mSTZ) was administered to GcgKO mice. The contribution of GIP to glucose metabolism in GcgKO mice was also investigated by experiments employing dipeptidyl peptidase IV (DPP4) inhibitor (DPP4i) or Gcg–Gipr double knockout (DKO) mice. RESULTS: GcgKO mice developed severe diabetes by hSTZ administration despite the absence of glucagon. Administration of mSTZ decreased pancreatic insulin content to 18.8 ± 3.4 (%) in GcgKO mice, but ad libitum-fed blood glucose levels did not significantly increase. Glucose-induced insulin secretion was marginally impaired in mSTZ-treated GcgKO mice but was abolished in mSTZ-treated DKO mice. Although GcgKO mice lack GLP-1, treatment with DPP4i potentiated glucose-induced insulin secretion and ameliorated glucose intolerance in mSTZ-treated GcgKO mice, but did not increase beta cell area or significantly reduce apoptotic cells in islets. CONCLUSIONS/INTERPRETATION: These results indicate that GIP has the potential to ameliorate glucose intolerance even under STZ-induced beta cell damage by increasing insulin secretion rather than by promoting beta cell survival. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-016-3935-2) contains peer-reviewed but unedited supplementary material, which is available to authorised users. |
format | Online Article Text |
id | pubmed-4901104 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-49011042016-06-27 Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin Iida, Atsushi Seino, Yusuke Fukami, Ayako Maekawa, Ryuya Yabe, Daisuke Shimizu, Shinobu Kinoshita, Keita Takagi, Yusuke Izumoto, Takako Ogata, Hidetada Ishikawa, Kota Ozaki, Nobuaki Tsunekawa, Shin Hamada, Yoji Oiso, Yutaka Arima, Hiroshi Hayashi, Yoshitaka Diabetologia Article AIMS/HYPOTHESIS: The action of incretin hormones including glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) is potentiated in animal models defective in glucagon action. It has been reported that such animal models maintain normoglycaemia under streptozotocin (STZ)-induced beta cell damage. However, the role of GIP in regulation of glucose metabolism under a combination of glucagon deficiency and STZ-induced beta cell damage has not been fully explored. METHODS: In this study, we investigated glucose metabolism in mice deficient in proglucagon-derived peptides (PGDPs)—namely glucagon gene knockout (GcgKO) mice—administered with STZ. Single high-dose STZ (200 mg/kg, hSTZ) or moderate-dose STZ for five consecutive days (50 mg/kg × 5, mSTZ) was administered to GcgKO mice. The contribution of GIP to glucose metabolism in GcgKO mice was also investigated by experiments employing dipeptidyl peptidase IV (DPP4) inhibitor (DPP4i) or Gcg–Gipr double knockout (DKO) mice. RESULTS: GcgKO mice developed severe diabetes by hSTZ administration despite the absence of glucagon. Administration of mSTZ decreased pancreatic insulin content to 18.8 ± 3.4 (%) in GcgKO mice, but ad libitum-fed blood glucose levels did not significantly increase. Glucose-induced insulin secretion was marginally impaired in mSTZ-treated GcgKO mice but was abolished in mSTZ-treated DKO mice. Although GcgKO mice lack GLP-1, treatment with DPP4i potentiated glucose-induced insulin secretion and ameliorated glucose intolerance in mSTZ-treated GcgKO mice, but did not increase beta cell area or significantly reduce apoptotic cells in islets. CONCLUSIONS/INTERPRETATION: These results indicate that GIP has the potential to ameliorate glucose intolerance even under STZ-induced beta cell damage by increasing insulin secretion rather than by promoting beta cell survival. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00125-016-3935-2) contains peer-reviewed but unedited supplementary material, which is available to authorised users. Springer Berlin Heidelberg 2016-04-06 2016 /pmc/articles/PMC4901104/ /pubmed/27053237 http://dx.doi.org/10.1007/s00125-016-3935-2 Text en © The Author(s) 2016 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Article Iida, Atsushi Seino, Yusuke Fukami, Ayako Maekawa, Ryuya Yabe, Daisuke Shimizu, Shinobu Kinoshita, Keita Takagi, Yusuke Izumoto, Takako Ogata, Hidetada Ishikawa, Kota Ozaki, Nobuaki Tsunekawa, Shin Hamada, Yoji Oiso, Yutaka Arima, Hiroshi Hayashi, Yoshitaka Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin |
title | Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin |
title_full | Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin |
title_fullStr | Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin |
title_full_unstemmed | Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin |
title_short | Endogenous GIP ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin |
title_sort | endogenous gip ameliorates impairment of insulin secretion in proglucagon-deficient mice under moderate beta cell damage induced by streptozotocin |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4901104/ https://www.ncbi.nlm.nih.gov/pubmed/27053237 http://dx.doi.org/10.1007/s00125-016-3935-2 |
work_keys_str_mv | AT iidaatsushi endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin AT seinoyusuke endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin AT fukamiayako endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin AT maekawaryuya endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin AT yabedaisuke endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin AT shimizushinobu endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin AT kinoshitakeita endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin AT takagiyusuke endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin AT izumototakako endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin AT ogatahidetada endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin AT ishikawakota endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin AT ozakinobuaki endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin AT tsunekawashin endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin AT hamadayoji endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin AT oisoyutaka endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin AT arimahiroshi endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin AT hayashiyoshitaka endogenousgipamelioratesimpairmentofinsulinsecretioninproglucagondeficientmiceundermoderatebetacelldamageinducedbystreptozotocin |